This article presents findings from a recent cross-sectional study that was designed to evaluate both the impact of erectile dysfunction (ED) on the lives of Australian men, and explore whether the use of PDE5 inhibitors was able to alter this impact. The sample comprised 410 men with ED, and 242 men who did not have ED. All men were primarily recruited over the internet via men's health web sites. Participants completed a questionnaire to assess their self-esteem, masculinity, quality of life, sexual satisfaction, relationship satisfaction and usage of oral ED medication. The results demonstrated that men with ED experienced deficits on all of the psychosocial areas when compared to men without ED. Moreover, treatment with ED medication did not alleviate this deficit. Implications of these findings for the treatment of men with ED are discussed in the context of the biopsychosocial model of health and the need for a multidisciplinary approach to ED management is highlighted.
Introduction
Sexual health has recently been prioritized as an area of people's lives that requires 'yprotecting, supporting and restoring' 1 (p.5) . This acknowledgement of the importance of sex has stemmed from a recognition that a healthy, satisfying sex life is a key element of successful relationships. 2 The presence of a sexual dysfunction, such as erectile dysfunction (ED), can cause significant interference to a person's sexual functioning and sexual health that can then have negative implications for their general feelings of well-being.
ED is a disorder of sexual arousal and affects up to 50% of men at some point in their lives, 3 and is widely treated with the use of oral medications, known as PDE5 inhibitors. These drugs have demonstrated effectiveness in being able to induce a physiological arousal response in the majority of men, although there are high levels of dissatisfaction and discontinuation rates among men who are treated with these mainline therapies. 4, 5 To account for these findings, it has recently been suggested that the medical approach to treatment of a sexual dysfunction does not take into account the various psychological and relationship factors that are often associated with the presence of ED, 6 and which are intimately connected to a person's sexual health.
For example, men with ED have reported that their ED represents a serious threat to their masculinity, self-esteem and quality of life (QOL). [7] [8] [9] Qualitative studies of men with ED have indicated that when ED develops, the changes the men experience in the areas of sexual intimacy, interactions with women and their thoughts about sex can undermine their masculine identities and challenge. 10, 11 This loss of masculinity appears also to generalize to an overall decline in self-esteem for men when ED develops, 12, 9 as well as declines in overall QOL. 7, 8 The presence of ED can also have significant implications for the relationships of men with this condition. Men with ED, and their partners, have been noted to experience declines in their sexual satisfaction and general relationship satisfaction with the presence of ED. 13, 14 While such findings are not surprising, given the importance of sex in intimate relationships, our understanding of the extent to which these declines occur and how the man experiences these relationship losses remain incomplete. Moreover, the ability of medical interventions to improve overall psychological and relationship functioning has not been well investigated.
This paper aims to explore the impact that ED has on the psychological well-being and relationships of men using the framework of the biopsychosocial model of health. 15 This model allows us to account for the biological, psychological and relationship factors that are inherent in sexual experience, particularly sexual arousal and ED.
It was hypothesized that men with ED would report a lower sense of masculinity, lower self-esteem, poorer QOL, lower sexual satisfaction and lower relationship satisfaction than men without ED. Given that the use of PDE5 medication may restore a man's sense of masculinity, it was also predicted that men who had used PDE5 medication to treat their ED would experience higher levels of masculinity, self-esteem, QOL, sexual satisfaction and relationship satisfaction than men with ED who had not tried these medications.
Materials and methods

Participants
Participants were 410 men who reported experiencing ED during the past 12 months (men with ED), and 242 who reported not experiencing ED in past 12 months (men without ED). The men were all residents in Australia, and men who did not meet this criterion were excluded from participation. Men with ED were significantly older (mean ¼ 55.7 years, s.d. ¼ 14.6), than men without ED (mean ¼ 34.1 years, s.d. ¼ 13.5), t(650) ¼ 18.77, Po0.01 (see Table 1 )
The majority of men with ED reported that they had experienced ED for at least 3 years. Most men with ED (85.6%) reported that they were currently in a sexual relationship, as were the majority of men without ED (77.2%). A summary of the duration and nature of these relationships is presented in Table 2 .
Materials
A number of items were included to explore the importance of sex and their relationship in the men's lives (rated on a five-point likert scale ranging from 'not at all important' to 'extremely important') and frequency of sexual activity per month (current and desired levels). To be classified as having ED in this study, men were asked to self-report (yes or no) if they had experienced some degree of difficulty attaining or maintaining an erection within the past 12 months. Men with ED were also asked to indicate whether they had taken oral PDE5 medication as treatment for their ED (yes or no).
Self-esteem, sexual satisfaction and relationship satisfaction were all assessed using subscales scored of the Self-Esteem and Relationship questionnaire (SEAR), 4 which measured men's responses to the items on a five-point likert scale ranging from 1 ¼ never/almost never and 5 ¼ always/almost always. Responses were provided in relation to how the items applied over the past 4 weeks. The SEAR self-esteem subscale comprised four items and showed good reliability for both men with ED, a ¼ 0.82, and men without ED, a ¼ 0.83, as did the sexual relationship subscale (eight items) for both men with ED, a ¼ 0.88, and men without ED, a ¼ 0.80. The SEAR overall relationship subscale (two items) also showed good reliability for men with ED, a ¼ 0.85, and for men without ED, a ¼ 0.84.
Masculinity was assessed using a single likertscale item from the Psychological Impact of Erectile Dysfunction scale that assessed the frequency with which men reported feeling they had lacked masculine confidence over the past 4 weeks (PIED). 7 Responses on this item ranged from 'almost always/always' to 'almost never/never'.
QOL was assessed with 25 items from the World Health Organisation Quality of Life Scales (WHO-QOL), 16 covering range of the measure's facets: Abbreviation: ED, erectile dysfunction.
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Overall Quality of Life and General Health (four items), Positive Feelings (two items), Self-esteem (four items), Body Image and Appearance (three items), Negative Feelings (three items), Activities of Daily Living (two items), Personal Relationships (three items) and Sexual Activity (four items). All responses were rated on five-point likert scales. Participants' overall score on these 25 items provided the measure of QOL. This measure showed good reliability overall for both groups, with a ¼ 0.94 for men with ED, and a ¼ 0.95 for men without ED.
Procedure
Following ethics approval from the University Human Research Ethics Committee, participants in this study were recruited via the internet by placing active links to the study's homepage on the google.com search engine and men's health websites, including Impotence Australia. Men who had taken part in a previous ED study were also sent letters to invite them to participate in our current study. These participants were provided details of the website, so that they could participate online, and were also given the option of participating by mail. A national media release of this project was also undertaken. Interviews were conducted on state-wide radio programs and articles printed in various press outlets. In total, 84.2% of participants chose to take part in this research online, while 15.8% took part via post. All participants submitted their questionnaire responses anonymously. Men took between 10 and 30 min to complete the questionnaire. When their questionnaires were completed, participants were given the option of providing their contact details (full name and address) in order to receive payment ($15.00 in recognition of their time commitment). This information was not connected to questionnaire responses and enabled questionnaire data to remain anonymous. In total, 78.5% of participants sought this payment.
Results
Of those men who were in relationships, a greater number of men with ED rated their relationship as being important or extremely important to them (80. 0%), than did men without ED (66.1%), To determine the association between ED and the psychological and relationship factors, a between-subject Multivariate Analysis of Covariance (MANCOVA) was conducted through SPSS MANCOVA. The dependent variables in this analysis were masculinity, self-esteem, QOL, sexual satisfaction and relationship satisfaction. The independent variable was the presence or absence of ED (see Table 3 Men with ED reported lower levels of masculinity, self-esteem, QOL, sexual satisfaction and relationship satisfaction than men without ED, after allowing for differences between the groups in age. Hence, our hypothesis was supported by the findings.
Among respondents with ED, 47.6% reported having used PDE5 medication as treatment for their ED, while 47.6% respondents reported not having tried this form of treatment. To determine whether the use of ED medication influenced men's levels of masculinity, self-esteem, QOL, sexual satisfaction and relationship satisfaction, these variables were included as dependent variable (DVs) in a between- The independent variable was use of PDE5 medication to treat the ED (see Table 4 for means and s.d.s for these variables). The MANOVA was non-significant, F(5,384) ¼ 0.72. Men with ED who had used treatment did not differ in their reported levels of these psychosocial variables from men with ED who had not used PDE5 medications as a treatment for their ED. Hence, our hypothesis was not supported by the findings.
Discussion
The results of the current study demonstrated that men with ED experienced significant deficits on all of the psychosocial variables when compared to men without ED, and this did not improve with the use of ED medication. Such findings are consistent with a growing body of literature that suggests that men with this sexual dysfunction experience deficits in their self-confidence, life satisfaction and relationships.
9-11
These results also lend support to the view that sexual competency and erectile functioning are central components in a man's overall self-concept and sense of manhood. 9 Our findings indicated that masculinity and self-esteem of men with ED were significantly lower than that of men without ED. Recent qualitative research has identified sexuality as being a key ingredient in current cultural conceptions of masculinity. 9, 10 Hence, the reduced sense of masculinity in men with ED is likely due to the importance that men place on sex, and the disruption that the presence of ED can cause to the sexual aspect of a man's life.
The finding that men with ED also reported significantly lower overall QOL is consistent with recent research that has noted that any interference in a person's sex life may have a strong relationship with their satisfaction with life as a whole. 7, 8, 18, 19 It has been well demonstrated that general and healthrelated QOL of men with ED are frequently impaired, 19 and that the presence of this sexual dysfunction is associated with many different areas of a man's QOL. For example, it has been shown in previous studies that men with ED report deficits in several broader areas of their life, including their general emotional satisfaction, general happiness, productivity, intimacy and safety. 17, 20 The psychological and QOL findings of the present study support the recent proposal by FuglMeyer et al. 18 that presence of ED has its impact on men's QOL because of the creation of a sexual aspiration-achievement gap. According to FuglMeyer et al., 18 when sex is regarded as an important aspect of a man's life, but he is unable to fulfil his sexual goals (for example, through presence of ED), the gap between sexual aspirations and achievement widens, resulting in an overall decline in QOL. Such a gap is evidenced in our sample of men with ED, as they placed greater importance on sex, and reported a lower current frequency and a higher desired frequency of sexual activity than men without ED. These findings suggest that men with ED are aware of the deficit in their sexual lives created by the presence of ED, and this leads to a decline in their overall life satisfaction. However, a longitudinal study is necessary to trace the direction of these relationships between ED and QOL.
The relationships of men with ED also appear to be impaired, as the results of the current study also demonstrated that men with ED reported a lower level of sexual satisfaction than men without ED. The reasons for this deficit could be related to the high level of importance that men with ED place on sex, their reaction to the presence of the ED, the individual psychological impact of the condition and the subsequent decline in the frequency of sexual activity when ED is present. Men with ED were engaging in sexual activity only about half as often as men without ED, making it likely that this deficit in their frequency of sexual activity was related to their overall decline in sexual satisfaction. Moreover, given the important role sex plays in intimate relationships, 2 it was not surprising that the overall relationship satisfaction was also impaired for men with ED. Again, the causative direction of the relationship between ED and both , strength of association.
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sexual and relationship satisfaction needs to be explored further using more detailed longitudinal research designs. These deficits remained even when the man used PDE5 inhibitors to treat his ED.
Limitations
There were several limitations to this study. No data regarding online response rates were captured and hence we are unable to determine the number of men who continued on to complete the study after reaching the project's homepage. Although access was enabled to a large national sample, collecting data online also presented an important limitation, in that we were unable to control for confounding factors that may have been possible through other methods (for example, face-to-face interview). In addition, while single-item self-report assessment of the presence of ED has been criticized in the literature 21 such a measure was beneficial to use in our sample, as men in this study were drawn from the general population and so may be resistant to extensive questioning on their ED. Clinical assessment tools have been noted to potentially be oversensitive and classify people from the general population as dysfunctional when they may not have perceived themselves as such, 21 and hence these assessment measures were deemed inappropriate for use in this study. It has been demonstrated that single-item measures of self-reported experiences of ED are able to predict clinically diagnosed ED with reasonable accuracy; 22 however, it is noted that validated measures of ED would be more appropriate and would have allowed comparison of participants' subjective ratings against a validated objective rating scale. Greater confidence could be placed in the causative nature of the relationships in the current study through the use of a longitudinal study design and through use of matched samples.
Conclusions
This study has enabled confirmation of the potential negative impact that the presence of ED may have on a man's psychological well-being and on his relationship with his partner. Moreover, this study highlighted the importance of taking a biopsychosocial approach to understanding and treating ED. PDE5 medications did not appear to alleviate the negative impact on masculinity, self-esteem, QOL, sexual satisfaction and relationship satisfaction of ED, highlighting the need for considering a multidisciplinary approach to treat for men who have demonstrated psychological or relationship issues in association with their ED. 23 While medical treatments will always remain a primary tool in treating this dysfunction, these interventions may not be sufficient to treat all cases of ED successfully. Further detailed and longitudinal exploration of how this sexual problem impacts on men and their partners will enable clear identification of those who may be dissatisfied with oral medications, or who may have a poor response to these treatments. Concurrent development of effective, efficient and affordable integrated biopsychosocial therapies warrant further attention, so that the inherent complexity of sexual health is recognized not only in the development of sexual problems but also in their successful treatment.
